Prescribing Nature: Neurobiological Rationale and Clinical Guidance for Clinicians

What are the most compelling, emerging neurobiological, physiological, or psychological mechanisms that explain the health benefits of nature exposure, and how have these mechanisms driven nature prescription research in the past decade?

John La Puma, MD: Nature prescriptions are written recommendations by a health care professional to patients to spend more intentional time outside in nature to improve physical and mental health. These prescriptions are no longer based primarily on correlational psychology. Instead, they are grounded in well-documented neurobiological, chronobiological, and physiological mechanisms. For example, cognitively, nature exposure has been shown to reduce rumination while replenishing directed attention through what researchers call “soft fascination.”

Nature prescriptions work by restoring core biological inputs—light, movement, sensory complexity, and microbial exposure—that regulate timing, metabolism, immunity, and brain function. For example, morning outdoor light has a powerful circadian clinical effect: It acts as the primary zeitgeber (time-keeper) for the suprachiasmatic nucleus through specialized retinal cells. Even on a cloudy day, outdoor light can deliver 10,000–25,000 lux, compared to 300–500 lux indoors. That intensity gap is not cosmetic; it is hormonal. It drives the cortisol awakening response, stabilizes dopamine signaling, and initiates the countdown for nighttime melatonin release. In contrast, even small amounts of artificial nighttime light disrupt circadian rhythm and increase the risk for myocardial infarction and congestive heart failure by over 50% and for stroke and atrial fibrillation by over 30%.

Intentional, specific nature engagement works not because it is relaxing or because it is a wellness modality, but because it restores temporal order to biological systems that are designed to run on time.

What does research show in regard to the detriments of spending too much time indoors?

Dr. La Puma: Spending too much time indoors negatively affects both physical and social health. Constantly being in indoor environments may pose significant neurological risks. For example, indoor CO₂ levels often exceed 1000 ppm, which has been correlated with approximately 15% impairment in decision-making. Chronic screen time leads to what some researchers call “digital obesity”: attentional constriction, anxiety, and mental exhaustion. Poor sleep quality, disrupted by the absence of essential biological inputs, also impairs glymphatic clearance of β-amyloid and tau proteins, increasing long-term dementia risk. Dim artificial light indoors creates a state of chronic biological twilight, which prevents the nocturnal suppression of ghrelin.

Indoor air can contain up to five times more pollutants than outdoor air. Research has shown that digital-induced social isolation carries mortality risks equivalent to smoking 15 cigarettes daily. Indoor confinement measurably lowers heart rate variability (HRV) and vagal tone, shifting the body toward sympathetic dominance and creating a pro-inflammatory state, and is a primary driver of chronic metabolic syndrome.

Children are deeply affected: Pediatric brains are still establishing circadian rhythms, building executive function, and wiring emotional regulation. When children spend most of their waking hours indoors, and then add high-frequency digital stimulation on top of that, the brain rarely enters the low-arousal states needed for consolidation, imagination, and self-soothing. Over time, this pattern is linked with sharp increases in pediatric anxiety, mood volatility, behavioral outbursts, sleep disruption, and attention disorders.

Screens are not the primary pathology; overstimulation layered on sensory and social deprivation delivers dense reward cues, artificial light, and continuous attentional demand, which the nervous system processes as high-intensity, low-recovery input. Insufficient outdoor natural light and off-device exposure contribute to the myopia epidemic. Regular outdoor exposure is the counterbalance. Screens may transmit information, but nature builds the neurological capacity to use it.

As lifestyle medicine practitioners, we focus on measurable outcomes. What are the most established physical and mental health benefits of nature prescriptions, and what are the current clinical recommendations (e.g., duration, frequency, and type of environment) for maximizing these outcomes?

Dr. La Puma: Nature exposure produces clinically significant improvements across cardiovascular, immune, metabolic, endocrine, and cognitive systems. Research shows that a single two-hour forest visit can reduce systolic blood pressure by approximately 7 mm Hg and diastolic by 4 mm Hg. Studies demonstrate cortisol reductions of about 20% after just 20–30 minutes outdoors.

Metabolic and cognitive benefits are equally robust. Diabetic patients show postprandial glucose reductions of approximately 40 mg/dL after forest walks—30–60 minutes per walk—most effective postprandially, repeated three to five times per week. Directed attention improves by roughly 20% after park exposure, compared to urban walking, and neuroimaging reveals decreased activation in brain regions associated with rumination and depression.

The magnitude of these effects reframes nature exposure as a legitimate therapeutic intervention rather than an adjunct. For example, green exercise lowers perceived exertion by approximately 20%, increasing adherence while improving cardiovascular outcomes. Gardening lowers HbA1c by roughly 0.5%, comparable to initiating first-line pharmacologic therapy. A single two-hour forest immersion increases natural killer cell activity by approximately 50%, with effects lasting up to 30 days.

These outcomes rival or complement standard interventions for hypertension, metabolic disease, immune dysfunction, and mood disorders, but without adverse effects. Importantly, benefits are dose-responsive but not time-intensive. Research consistently shows that 120 minutes per week in nature represents a minimum effective threshold, while as little as 11 minutes per day of moderate activity is associated with a 23% reduction in premature mortality. This positions Outdoor Rx as a high-yield, low-risk intervention ideally suited to evaluation and prescription.

Clinicians have so much to cover in any one appointment—how does one simply add this nature prescription to their conversations with patients?

Dr. La Puma: Successful integration requires proper framing. Nature exposure should be prescribed as essential medicine with specific dosing and expected effects. Patients aren’t simply stressed but are experiencing biological responses to prolonged indoor confinement. This framing improves compliance by attributing symptoms to a physiological cause rather than personal failure.

Clinicians can begin with brief assessments of baseline outdoor exposure and preferences, then prescribe microdoses designed to minimize activation energy. For example, prescribing 10 minutes of morning light exposure outside represents an economical intervention targeting circadian repair.

Clinically relevant outdoor and environmental therapies ranked by strength of evidence: A.

Strong evidence (RCTs, large cohorts, and reproducible physiological data). •

Morning outdoor light exposure (10–15 minutes within 90 minutes of waking): Strong circadian, sleep, metabolic, and mood benefits demonstrated in multiple randomized and mechanistic studies.

Microinterventions outperform aspirational goals. These interventions require no equipment, carry minimal risk, are free or of modest cost, and can be scaled based on patient response.

What are some critical resources for clinicians in regard to helping their patients get outside? Are there grassroots movements such as Walk with a Doc?

Dr. La Puma: Established programs help clinicians prescribe nature without creating infrastructure from scratch. Park Rx provides standardized resources and partnerships with local parks, while Walk with a Doc offers a scalable model combining movement, social connection, and outdoor exposure. Prescription Trails and similar regional programs adapt outdoor activities for patients with chronic conditions. Our site, www.IndoorEpidemic.com offers a roadmap for clinicians and patients, including device recommendations, and the summary Cheat Sheet, designed to make simple, quick nature-based interventions accessible, effective and family-friendly.

These resources reduce burden by outsourcing logistics and providing community-level reinforcement. Referrals to outdoor educators or recreational therapists extend care beyond the clinic while maintaining medical oversight. Importantly, such programs legitimize nature prescriptions within health care systems by connecting them to existing public health infrastructure.

Clinicians can access peer-reviewed research and implementation guidance through organizations such as the Children & Nature Network, the EnviroAtlas of the Environmental Protection Agency, the Global Wellness Institute, the Nature and Health Alliance, NHS Forest, the UK Nature-based Solutions (NbS) Knowledge Hub, and the World Health Organization NbS.

Structured nature-based prescriptions can offer a scalable, physician-directed intervention rather than an uncompensated counseling burden. Several recurrent patient groups appear to benefit, including the burned-out indoor professional with chronic insomnia, anxiety, and hypertension; the overloaded parent managing children with screen-associated behavioral concerns, ADHD, and obesity; the metabolically dysregulated adult with prediabetes, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease; and the longevity-focused patient at risk for mild cognitive impairment or concerned about accelerated cognitive decline.

These populations are well suited to individual counseling, group visits, preventive care programs, employer-sponsored wellness initiatives, and structured educational offerings. When framed as biology-based clinical care, nature prescriptions can be evaluated alongside other lifestyle interventions for effects on measurable outcomes (e.g., blood pressure, HbA1c, weight, mood scores, and cognitive performance). If physicians do not guide this emerging area, it is likely to be shaped predominantly by nonclinical wellness narratives that lack medical oversight and scientific rigor.

For readers seeking a more detailed review of the evidence base, clinical protocols, and practical tools, further information is available in Indoor Epidemic: 93% Inside Steals Sleep, Focus & Years—The 7% Outdoor Rx Restores Them (Wellness Imprints, 2026 March).

What do you hope for the future in terms of clinicians integrating this into their clinical practice?

Dr. La Puma: The next phase involves identifying nature engagement as primary medicine with other pillars of lifestyle medicine. This means deploying and evaluating specific testable outdoor prescriptions within routine preventive care, chronic disease management, and mental health treatment with the same rigor as pharmacologic interventions.

The evidence base must continue to mature around clinician-delivered prescriptions, standardized dosing protocols, and population-specific response patterns. Improving access, especially for the disadvantaged and underserved, is equally critical. Clinicians prescribe more confidently when interventions are measurable, scalable, and realistic for their patients. Health care systems that partner with parks, schools, landscape architects, forward-thinking private organizations, and urban planners will maximize downstream benefits.

Finally, sustained focus on quantifiable biomarkers will accelerate adoption. Tracking HRV, cortisol and insulin levels, inflammatory markers, sleep consistency, cognitive performance, and gait speed provides objective data that clinicians can act upon. These markers consistently respond to circadian alignment, daylight exposure, movement in natural environments, and reduced indoor load. Addressing the indoor epidemic through nature prescriptions represents a strategy for extending health span by restoring biological coherence through environmental inputs to which human physiology is evolutionarily adapted.

Addressing the indoor epidemic through structured nature prescriptions is not an alternative strategy. It is a biologically grounded approach to extending health span. By restoring environmental signals to which human physiology is evolutionarily adapted, we reenable the body’s native repair programs, slow biological aging, and improve resilience across systems that modern indoor life has hijacked.▪

To Contact Dr. John La Puma

John La Puma, MD